| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1987PNAS...84.5277F |
| P356 | DOI | 10.1073/PNAS.84.15.5277 |
| P932 | PMC publication ID | 298838 |
| P698 | PubMed publication ID | 2440047 |
| P5875 | ResearchGate publication ID | 20716157 |
| P2093 | author name string | Fràter-Schröder M | |
| Risau W | |||
| Böhlen P | |||
| Hallmann R | |||
| Gautschi P | |||
| P2860 | cites work | Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity | Q24301401 |
| An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 | ||
| Identity of tumour necrosis factor and the macrophage-secreted factor cachectin | Q28286678 | ||
| Acidic fibroblast growth factor (FGF) from bovine brain: amino-terminal sequence and comparison with basic FGF | Q33931601 | ||
| The labelling of blood cells in plasma with 111In-tropolonate | Q70306339 | ||
| Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin | Q34258651 | ||
| Antiadhesive properties of biological surfaces are protective against stimulated granulocytes | Q34548045 | ||
| Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro | Q35586782 | ||
| Developing brain produces an angiogenesis factor | Q35608426 | ||
| Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro | Q35610349 | ||
| Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1 | Q35612515 | ||
| Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers | Q35835763 | ||
| Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein | Q36212130 | ||
| Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells | Q36350042 | ||
| Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts | Q36351406 | ||
| Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors | Q36351673 | ||
| Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 | Q36351905 | ||
| Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor | Q37401986 | ||
| Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. | Q37534320 | ||
| Isolation and partial molecular characterization of pituitary fibroblast growth factor | Q37565401 | ||
| Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor | Q37576712 | ||
| Necrosin: purification and properties of a cytotoxin derived from a murine macrophage-like cell line | Q37580750 | ||
| Cachectin and tumour necrosis factor as two sides of the same biological coin | Q39501245 | ||
| The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers | Q41141776 | ||
| Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin | Q41776641 | ||
| Modulation of endothelial cell hemostatic properties by tumor necrosis factor | Q42151543 | ||
| Transforming growth factor-beta inhibits endothelial cell proliferation | Q42520375 | ||
| Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. | Q42520814 | ||
| Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor | Q43819326 | ||
| Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. | Q44045134 | ||
| Antiviral effects of recombinant tumour necrosis factor in vitro | Q44422722 | ||
| Mechanism of the cytotoxic effect of tumor necrosis factor | Q45352028 | ||
| Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons | Q45848193 | ||
| Cancer. Cell growth control mechanisms. | Q53535457 | ||
| Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. | Q53541288 | ||
| Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2 | Q53810509 | ||
| Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. | Q54779287 | ||
| Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. | Q54784059 | ||
| Inhibition of endothelial cell proliferation by type β-transforming growth factor: Interactions with acidic and basic fibroblast growth factors | Q56429120 | ||
| Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor | Q56429774 | ||
| Inhibitory effect of tumor necrosis serum on the metastasis of B-16 mouse melanoma cells | Q58207841 | ||
| Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage | Q59063497 | ||
| Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets | Q68732884 | ||
| Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages | Q68798142 | ||
| The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Studies with vascular smooth muscle cells and endothelial cells | Q68947407 | ||
| A chemiluminescent assay for mycoplasmas in cell cultures | Q70074607 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| cell growth | Q189159 | ||
| P304 | page(s) | 5277-5281 | |
| P577 | publication date | 1987-08-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo | |
| P478 | volume | 84 |
| Q62071701 | 15-hydroxyeicosatetraenoic acid stimulates migration of human retinal microvessel endothelium in vitro and neovascularization in vivo |
| Q59071772 | A family of angiogenic peptides |
| Q34435654 | A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways |
| Q67804693 | A morphological study of the rabbit corneal assay |
| Q79848901 | A new role for the anti-apoptotic gene A20 in angiogenesis |
| Q39634814 | A novel role for TNFAIP2: its correlation with invasion and metastasis in nasopharyngeal carcinoma. |
| Q41140320 | A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction). |
| Q30642656 | Aberrant phenotype in human endothelial cells of diabetic origin: implications for saphenous vein graft failure? |
| Q37397839 | Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells. |
| Q41756880 | Acidic fibroblast growth factor (aFGF) is present in the fluid of brain tumour pseudocysts |
| Q67677223 | Actions of TNF and INF-γ on Angiogenesis In Vitro |
| Q38730363 | Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression |
| Q34187040 | Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscle |
| Q39716254 | Adipocyte-derived microvesicles are associated with multiple angiogenic factors and induce angiogenesis in vivo and in vitro |
| Q36602451 | Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. |
| Q40656846 | Aetiology and pathogenesis of chronic inflammatory bowel disease |
| Q42137691 | Aetiology of Crohn's disease |
| Q36616466 | An important role of blood and lymphatic vessels in inflammation and allergy |
| Q35833238 | Analysis of p60 and p80 tumor necrosis factor-alpha receptor messenger RNA and protein in human placentas. |
| Q35327839 | Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications |
| Q37534974 | Angiogenesis drives psoriasis pathogenesis |
| Q36665512 | Angiogenesis in arteries: Review |
| Q35627784 | Angiogenesis in non-small cell lung cancer. A new target for therapy |
| Q40833417 | Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies |
| Q33598141 | Angiogenesis in urological malignancy: prognostic indicator and therapeutic target |
| Q36231174 | Angiogenesis inhibition suppresses collagen arthritis |
| Q29614538 | Angiogenesis: an organizing principle for drug discovery? |
| Q67661947 | Angiogenesis: its importance in normal eye growth and in ocular pathology |
| Q40400185 | Angiogenesis: models and modulators. |
| Q71686554 | Angiogenic activity in normal and dysfunctional uterine bleeding human endometrium; as measured by the chick chorioallantoic membrane assay |
| Q35207666 | Angiogenic factors in the central nervous system |
| Q30498863 | Angiogenic growth factors in neural embryogenesis and neoplasia |
| Q42614337 | Angiogenic stimulation compared with angiogenic reaction to injury: distinction by focal and general application of trypsin to the chick chorioallantoic membrane |
| Q24338389 | Angiogenin activates endothelial cell phospholipase C |
| Q24338956 | Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2 |
| Q34101582 | Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma |
| Q36673663 | Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases |
| Q72096738 | Anti-angiogenesis: a multipurpose therapeutic tool? |
| Q33484188 | Anti-inflammatory thalidomide improves islet grafts survival and functions in a xenogenic environment |
| Q39704685 | Antiangiogenic activity of ursolic acid. |
| Q73581110 | Antioxidants inhibit TNFalpha-induced motility and invasion of human osteosarcoma cells: possible involvement of NFkappaB activation |
| Q44522511 | Ascorbic acid blocks the growth inhibitory effect of tumor necrosis factor-alpha on endothelial cells |
| Q77338541 | Autoregulation of angiogenesis by cells of the vessel wall |
| Q34292002 | Biology of Kaposi's sarcoma |
| Q38410101 | Breaking the 'harmony' of TNF-α signaling for cancer treatment |
| Q39527191 | Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses |
| Q39555654 | Cachetin/TNF: a macrophage protein that induces cachexia and shock |
| Q34522531 | Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis |
| Q45900350 | Cell death and the regulation of populations of cells in the periodontal ligament. |
| Q73955405 | Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels |
| Q40894019 | Changes of angiogenin serum concentrations in the perinatal period |
| Q46173314 | Clinical and biochemical studies of bone destruction in cholesteatoma |
| Q33834836 | Cloned endothelial cells from fetal bovine bone |
| Q41827841 | Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity |
| Q33962049 | Current status of antiangiogenic factors |
| Q40437888 | Cutaneous Necrosis, Telangiectatic Matting, and Hyperpigmentation following Sclerotherapy Etiology, Prevention, and Treatment |
| Q67486148 | Cyclic AMP potentiates bFGF‐induced neurite outgrowth in PC12 cells |
| Q38331819 | Cyclooxygenase gene expression is down-regulated by heparin-binding (acidic fibroblast) growth factor-1 in human endothelial cells |
| Q47953009 | Cytokines and blood-brain barrier permeability |
| Q40896076 | Cytokines, sepsis and immunomodulation |
| Q71745250 | Cytoprotective mechanisms in cultured cardiomyocytes |
| Q22000875 | Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study |
| Q41957297 | Decreased level of transforming growth factor-beta in blood lymphocytes of patients with aplastic anemia |
| Q47901337 | Detection of Fcgamma receptors on human endothelial cells stimulated with cytokines tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma). |
| Q45010716 | Development of subrenal capsule tumours following transplantation of rat RN6 multicell spheroids |
| Q73980573 | Differences in angiogenic potential of classically vs alternatively activated macrophages |
| Q35874063 | Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants |
| Q39875172 | Differential expression and regulation of nuclear oligomerization domain proteins NOD1 and NOD2 in human endometrium: a potential role in innate immune protection and menstruation. |
| Q46044609 | Differential expression of angiogenic cytokines by cell lines and primary cultures of human prostate cancer |
| Q38349602 | Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor. |
| Q37357812 | Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells |
| Q35830630 | Dual role of tumor necrosis factor-alpha in angiogenesis |
| Q35773527 | E-selectin is present in proliferating endothelial cells in human hemangiomas. |
| Q42465245 | Effect of inflammatory cytokines on human endothelial cell proliferation |
| Q71825451 | Effects of TNF-α on the Production of Vasoactive Substances by Cerebral Endothelial and Smooth Muscle Cells in Culture |
| Q39793344 | Effects of enamel matrix derivative on proliferation/viability, migration, and expression of angiogenic factor and adhesion molecules in endothelial cells in vitro. |
| Q35830367 | Effects of recombinant tumor necrosis factor-alpha on cultured pulmonary artery and lung microvascular endothelial monolayers |
| Q40533421 | Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation. |
| Q41862848 | Endothelial cell activation induced by tumor necrosis factor and lymphotoxin |
| Q36375147 | Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells |
| Q36361731 | Enhancement of experimental metastasis by tumor necrosis factor |
| Q48632619 | Ephrin-A3 and ephrin-A4 contribute to microglia-induced angiogenesis in brain endothelial cells |
| Q33610623 | Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland |
| Q38263810 | Epigenetic Interactions and Gene Expression in Peri-Implantation Mouse Embryo Development |
| Q42372220 | Epithelial ovarian cancer: a cytokine propelled disease? |
| Q24540207 | Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis |
| Q28207963 | Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway |
| Q34770132 | Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand |
| Q47788500 | Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma |
| Q47675246 | Expression of angiogenic factors in neurofibromas |
| Q50279952 | Expression of vascular endothelial growth factor and other cytokines in atopic dermatitis, and correlation with clinical features. |
| Q47872949 | Expression of vascular endothelial growth factor in human hepatocellular carcinoma |
| Q33737210 | Extracellular matrix modulates angiogenesis in physiological and pathological conditions |
| Q33791689 | Factors promoting tumor angiogenesis |
| Q67700808 | Functional evaluation of tumor-infiltrating mononuclear cells. Detection of endogenous interferon-γ and tumor necrosis factor-α in human colorectal adenocarcinomas |
| Q48548439 | Gene expression of IL-10 in relationship to TNF-alpha, IL-1beta and IL-2 in the rat brain following middle cerebral artery occlusion |
| Q35410698 | Genetic deletion of TNFR2 augments inflammatory response and blunts satellite-cell-mediated recovery response in a hind limb ischemia model |
| Q59071792 | Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate |
| Q48343706 | Growth regulation of cultured endothelial cells by inflammatory cytokines: mitogenic, anti-proliferative and cytotoxic effects. |
| Q24685277 | Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases |
| Q44106960 | Helicobacter pylori prevents proliferative stage of angiogenesis in vitro: role of cytokines. |
| Q38808589 | Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery |
| Q41100541 | How tumors become angiogenic |
| Q73979648 | Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells |
| Q40813221 | Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release |
| Q37350460 | Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression |
| Q28236903 | Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor |
| Q39496507 | Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis |
| Q45199522 | Immunolocalization of an angiogenic factor (HAF) in normal, inflammatory and tumor tissues |
| Q35172771 | Impact of Endothelial Activation on Fibrinolysis and Local Proteolysis in Tissue Repair |
| Q51466555 | Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1. |
| Q60495159 | Importance of monocytes/macrophages and fibroblasts for healing of micronecroses in porcine myocardium |
| Q42465684 | In situ detection of basic fibroblast growth factor by highly specific antibodies |
| Q36956349 | In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi |
| Q43051041 | In vivo targets of recombinant human tumour necrosis factor-alpha: blood flow, oxygen consumption and growth of isotransplanted rat tumours |
| Q73908738 | Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma |
| Q49597740 | Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity |
| Q35027107 | Infection and cancer: the common vein. |
| Q46096448 | Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit. |
| Q35811450 | Inhalation of chrysotile asbestos induces rapid cellular proliferation in small pulmonary vessels of mice and rats |
| Q24298587 | Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides |
| Q41895657 | Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression |
| Q38585255 | Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. |
| Q55472387 | Inhibition of tumor-induced angiogenesis by a synthetic lipid A analogue with low endotoxicity, DT-5461. |
| Q35308058 | Inhibitors of angiogenesis |
| Q36725418 | Interaction of T Lymphocytes with Cerebral Endothelial Cells in vitro |
| Q52229205 | Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo |
| Q39150057 | Interaction of endothelial cells with macrophages-linking molecular and metabolic signaling |
| Q46209142 | Interaction of estrogen and tumor necrosis factor alpha in endothelial cell migration and early stage of angiogenesis |
| Q41941549 | Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects |
| Q36670334 | Interactions between Endothelial Cells and the Cells of the Immune System |
| Q74489334 | Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor |
| Q42453478 | Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways |
| Q33757605 | Interleukin 1 is an autocrine regulator of human endothelial cell growth |
| Q24316308 | Interleukin 6 induces the expression of vascular endothelial growth factor |
| Q36952038 | Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages |
| Q67903127 | Interleukin-6 stimulates motility of vascular endothelium |
| Q40575606 | Intraperitoneal bispecific antibody (HEA125xOKT3) therapy inhibits malignant ascites production in advanced ovarian carcinoma |
| Q36569348 | Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis |
| Q33592542 | Is extravasation a Fas-regulated process? |
| Q40647293 | Isolation and characterization of a macrophage-derived heparin-binding growth factor. |
| Q55219010 | Isolation and properties of tumor-derived endothelial cells from rat KMT-17 fibrosarcoma. |
| Q36254201 | JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells |
| Q31046219 | Laser photocoagulation for corneal stromal vascularization |
| Q35664202 | Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity |
| Q38705161 | Macrophage-derived growth factors in wound healing: regulation of growth factor production by the oxygen microenvironment |
| Q35041234 | Macrophage-derived tumor necrosis factor-alpha is an early component of the molecular cascade leading to angiogenesis in response to aortic injury |
| Q34580805 | Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor |
| Q41508919 | Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy |
| Q41320685 | Mechanism of angiogenic effects of saponin from Ginseng Radix rubra in human umbilical vein endothelial cells |
| Q33676747 | Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors |
| Q37629825 | Mediators of neovascularization and the hypoxic cornea |
| Q34467962 | Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1. |
| Q36535834 | Modulation of the immune system by mammary tumor-derived factors |
| Q37223789 | Molecular Biology of Cytokine Effects on Vascular Endothelial Cells |
| Q40832214 | Molecular approaches to cancer therapy. |
| Q35182521 | Molecular aspects of pathological processes in the artery wall |
| Q34325744 | Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis |
| Q37376876 | Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb |
| Q52044245 | Murine psoriasis-like disorder induced by naive CD4+ T cells. |
| Q33561186 | Neovascularisation and its role in the osteoarthritic process |
| Q33708722 | Neutrophil dependence of vascular remodeling after Mycoplasma infection of mouse airways |
| Q34662099 | Nitric oxide and TNFα are critical regulators of reversible lymph node vascular remodeling and adaptive immune response |
| Q35763856 | Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. |
| Q42477969 | Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis |
| Q68726675 | Opposite effects of monokines (interleukin-1 and tumor necrosis factor) on proliferation and heparin-binding (fibroblast) growth factor binding to human aortic endothelial and smooth muscle cells |
| Q55309370 | Parallels between single cell migration and barrier formation: The case of RhoB and Rac1 trafficking. |
| Q47847636 | Periostin increases migration and proliferation of human periodontal ligament fibroblasts challenged by tumor necrosis factor -α and Porphyromonas gingivalis lipopolysaccharides |
| Q47687341 | Phenotypic modulation of cultured endothelial cells in collagen matrices induced by tumor necrosis factor alpha. |
| Q37461121 | Pim protein kinase-3 is regulated by TNF-α and promotes endothelial cell sprouting |
| Q36795204 | Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor |
| Q35752847 | Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis |
| Q34633192 | Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart. |
| Q35220307 | Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism |
| Q41015545 | Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway |
| Q67488282 | Purification of platelet-derived endothelial cell growth inhibitor and its characterization as transforming growth factor-β type 1 |
| Q34992789 | Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy |
| Q70373698 | Rapid phosphorylation of a 27 kDa protein induced by tumor necrosis factor |
| Q36670521 | Regulation of Plasminogen Activator Production by Endothelial Cells: Role in Fibrinolysis and Local Proteolysis |
| Q73454709 | Regulation of the release of tumour necrosis factor (TNF)alpha and soluble TNF receptor by gamma irradiation and interferon gamma in Ewing's sarcoma/peripheral primitive neuroectodermal tumour cells |
| Q34287035 | Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization |
| Q93738794 | Reply |
| Q43817800 | Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion |
| Q35546661 | Role of endothelial cell survival and death signals in angiogenesis |
| Q35805773 | Role of midkine-progranulin interaction during angiogenesis of hepatocellular carcinoma |
| Q58831756 | Role of tumor necrosis factor-α and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis |
| Q36141804 | Scatter factor induces blood vessel formation in vivo |
| Q37378024 | Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. |
| Q37426831 | Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis |
| Q73509045 | Social isolation stress augments angiogenesis induced by colon 26-L5 carcinoma cells in mice |
| Q34316575 | Specific binding of angiogenin to calf pulmonary artery endothelial cells |
| Q42003298 | Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO). |
| Q35811348 | Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis |
| Q38413494 | Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease |
| Q33323527 | TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype |
| Q30490532 | TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice |
| Q46252047 | TNF-alpha employs a protein-tyrosine phosphatase to inhibit activation of hepatocyte growth factor receptor and hepatocyte growth factor-induced endothelial cell proliferation |
| Q35642213 | TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage |
| Q54321573 | TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling. |
| Q35774251 | TRAF6 inhibits proangiogenic signals in endothelial cells and regulates the expression of vascular endothelial growth factor. |
| Q108502920 | Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators |
| Q41232618 | Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells |
| Q24563363 | Thalidomide is an inhibitor of angiogenesis |
| Q43596294 | Thalidomide revisited: pharmacology and clinical applications |
| Q38360146 | The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells |
| Q34390734 | The acute phase reactant orosomucoid-1 is a bimodal regulator of angiogenesis with time- and context-dependent inhibitory and stimulatory properties |
| Q40802362 | The biology of the artery wall in atherogenesis. |
| Q36098582 | The cutaneous vascular system in chronic skin inflammation |
| Q73144075 | The effect of pentoxifylline on the healing of intestinal anastomosis in rats with experimental obstructive jaundice |
| Q81041237 | The effect of thalidomide on vascular endothelial growth factor and tumor necrosis factor-alpha levels in retinal ischemia/reperfusion injury |
| Q50478730 | The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients. |
| Q24671121 | The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression |
| Q24534479 | The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. |
| Q43085902 | The importance of interleukin 1beta in Helicobacter pylori associated disease |
| Q33728467 | The lack of ADAM17 activity during embryonic development causes hemorrhage and impairs vessel formation |
| Q41508912 | The preclinical evaluation of angiogenesis inhibitors |
| Q33706710 | The rationale and future potential of angiogenesis inhibitors in neoplasia |
| Q39538513 | The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis |
| Q40401867 | The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis |
| Q40536226 | The stress response to trauma and critical illness. |
| Q59699226 | The study of cytokine dynamics at the operation site after mastectomy |
| Q44637808 | Tnfa and Il‐10 deficiencies have contrasting effects on lung tumor susceptibility: Gender‐dependent modulation of IL‐10 haploinsufficiency |
| Q37118844 | Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin |
| Q55240904 | Tumor Necrosis Factor-p Gene Expression and Its Relationship to the Clinical Features and Histopathogenesis of Peripheral T-Cell Lymphomas |
| Q37743207 | Tumor angiogenesis: insights and innovations |
| Q44755132 | Tumor necrosis factor activates CRE-binding protein through a p38 MAPK/MSK1 signaling pathway in endothelial cells |
| Q34594843 | Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection |
| Q41930910 | Tumor necrosis factor alpha increases antifibrinolytic activity of cultured human mesangial cells |
| Q35830416 | Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation |
| Q74428396 | Tumor necrosis factor alpha regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats |
| Q36363315 | Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. |
| Q33899892 | Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression |
| Q34231725 | Tumor necrosis factor improves vascularization in osteogenic grafts engineered with human adipose-derived stem/stromal cells |
| Q41828889 | Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro |
| Q36851476 | Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells |
| Q31865008 | Tumor necrosis factor-alpha but not interleukin-1 beta or interleukin-8 concentrations correlate with angiogenic activity of peritoneal fluid from patients with minimal to mild endometriosis. |
| Q28299110 | Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin |
| Q42716265 | Tumor necrosis factor-α signaling via TNFR1/p55 is deleterious whereas TNFR2/p75 signaling is protective in adult infarct myocardium |
| Q41172555 | Tumor-necrosis-factor-induced fibroblast growth factor-1 acts as a survival factor in a transformed endothelial cell line. |
| Q35580769 | Tumour necrosis factor alpha concentration and collateral flow in patients with coronary artery disease and normal systolic left ventricular function |
| Q61819217 | Tumour necrosis factor and cancer |
| Q68350435 | Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine |
| Q40403280 | Tumour vasculature--a potential therapeutic target |
| Q38248554 | Two natural glucomannan polymers, from Konjac and Bletilla, as bioactive materials for pharmaceutical applications |
| Q39788385 | Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites |
| Q35623604 | URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway. |
| Q67759071 | Ubiquitous Expression of TNF-α/Cachectin Immunoreactivity in Human Endometrium |
| Q36014743 | Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2. |
| Q57005503 | Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer |
| Q28300434 | Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis |
| Q42600448 | Vascularisation in adipose depots surrounding immune-stimulated lymph nodes |
| Q27028225 | Vitreous mediators in retinal hypoxic diseases |
| Q41888072 | Vulnerability of vascular endothelium in lipopolysaccharide toxicity: effect of (acyl) carnitine on endothelial stability |
| Q35830887 | c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans |
Search more.